Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools

British Journal of Pharmacology

Volumn 153, Issue 1, 2008, Pages 140-147

  Salomone, S ^a   Potts, E M ^a   Tyndall, S ^a   Ip, P C ^a   Chun, J ^b   Brinkmann, V ^c   Waeber, C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Basilar artery; FTY720; JTE 013; S1P; SEW2871; VPC23019

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ENDOTHELIN 1; JTE 013; PHOSPHO FTY 720; SPHINGOSINE 1 PHOSPHATE RECEPTOR; THROMBOXANE DERIVATIVE; UNCLASSIFIED DRUG; VPC 23019;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMORAL ARTERY; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; OXADIAZOLES; PROPYLENE GLYCOLS; PYRAZOLES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; THIOPHENES; VASOCONSTRICTION;

EID: 37849001331     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707581     Document Type: Article

References (33)

1. Anliker B, Chun J (2004). Lysophospholipid G protein-coupled receptors. J Biol Chem 279: 20555-20558.
2. Bandhuvula P, Tam YY, Oskouian B, Saba JD (2005). The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J Biol Chem 280: 33697-33700.
3. Bischoff A, Czyborra P, Meyer Zu Heringdorf D, Jakobs KH, Michel MC (2000). Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 130: 1878-1883.
4. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R et al. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453-21457.
5. Coussin F, Scott RH, Wise A, Nixon GF (2002). Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 91: 151-157.
6. Davis MD, Clemens JJ, Macdonald TL, Lynch KR (2005). Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 280: 9833-9841.
7. Gardell SE, Dubin AE, Chun J (2006). Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 12: 65-75.
8. Hla T, Maciag T (1990). An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265: 9308-9313.
9. Igarashi J, Bernier SG, Michel T (2001). Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276: 12420-12426.
10. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T (2003). VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci USA 100: 10664-10669.
11. Igarashi J, Michel T (2000). Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem 275: 32363-32370.
12. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ et al. (2001). Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 276: 33697-33704.
13. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA et al. (2002). Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem 277: 25152-25159.
14. Jo E, Sanna MG, Gonzalez-Cabrera PJ, Thangada S, Tigyi G, Osborne DA et al. (2005). S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem Biol 12: 703-715.
15. Lee MJ, Evans M, Hla T (1996). The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J Biol Chem 271: 11272-11279.
16. Leiber D, Banno Y, Tanfin Z (2007). Exogenous sphingosine 1-phosphate and sphingosine kinase activated by endothelin-1 induced myometrial contraction through differential mechanisms. Am J Physiol Cell Physiol 292: C240-C250.
17. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H et al. (2003). Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278: 40330-40336.
18. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J et al. (2002). Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349.
19. McGiffert C, Contos JJ, Friedman B, Chun J (2002). Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis. FEBS Lett 531: 103-108.
20. Mulvany MJ, Halpern W (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
21. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A et al. (2000). Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352 (Part 3): 809-815.
22. Nofer JR, van der Giet M, Tolle M, Wolinska I, von Wnuck Lipinski K, Baba HA et al. (2004). HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113: 569-581.
23. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H et al. (2003). Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 58: 170-177.
24. Okazaki H, Ishizaka N, Sakurai T, Kurokawa K, Goto K, Kumada M et al. (1993). Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun 190: 1104-1109.
25. Osada M, Yatomi Y, Ohmori T, Ikeda H, Ozaki Y (2002). Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 299: 483-487.
26. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA et al. (2003). S1P(3) receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469: 125-134.
27. Tolle M, Levkau B, Keul P, Brinkmann V, Giebing G, Schonfelder G et al. (2005). Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 96: 913-920.
28. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T et al. (2001). Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32: 2913-2919.
29. Waeber C, Blondeau N, Salomone S (2004). Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. Drug News Perspect 17: 365-382.
30. Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, Jo E et al. (2005). Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6: 1228-1235.
31. Yang AH, Ishii I, Chun J (2002). In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim Biophys Acta 1582: 197-203.
32. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N et al. (1997). Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 121: 969-973.
33. Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, Sano T et al. (2000). Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96: 3431-3438.